BCM
EDIT icon

Bridgeway Capital Management’s Editas Medicine EDIT Stock Holding History

Bridgeway Capital Management’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$408K Hold
126,000
– – 0.01% 898
2026
Q1 		$311K Buy
126,000
+50,000
+66% +$106K 0.01% 921
2025
Q4 		$156K Hold
76,000
– – ﹤0.01% 1058
2025
Q3 		$264K Sell
76,000
-44,000
-37% -$123K 0.01% 958
2025
Q2 		$264K Buy
120,000
+100,000
+500% +$164K 0.01% 899
2025
Q1 		$23.2K Sell
20,000
-130,000
-87% -$191K ﹤0.01% 1150
2024
Q4 		$191K Buy
+150,000
New +$382K ﹤0.01% 1021

Other funds holding EDIT

TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
WP
Woodline Partners San Francisco, California $32.4B AUM 58.5% 1-Year Est. Return

Bridgeway Capital Management's EDIT Position: Q2 2026 in Review

Bridgeway Capital Management held its Editas Medicine (EDIT) position steady in Q2 2026 at 126,000 shares worth $408K. The position accounts for 0.01% of the portfolio, ranked #898.

Bridgeway Capital Management first reported a position in EDIT in Q4 2024 and has held it in 7 quarters since. 216 funds tracked by Wall St. Rank hold EDIT as of Q2 2026.

  • Bridgeway Capital Management held 126,000 shares of Editas Medicine worth $408K as of Q2 2026.
  • Bridgeway Capital Management left its Editas Medicine share count unchanged in Q2 2026.
  • Editas Medicine made up 0.01% of Bridgeway Capital Management's portfolio in Q2 2026, its #898 holding.
  • Bridgeway Capital Management first reported a position in Editas Medicine in Q4 2024 and has held it in 7 quarters since.
  • 216 funds tracked by Wall St. Rank held Editas Medicine as of Q2 2026.

Based on Bridgeway Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.